Antimicrobial chlorhexidine/silver sulfadiazine-coated central venous catheters versus those uncoated in patients undergoing allogeneic stem cell transplantation.
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Only a minimum is known about clinical effect of antimicrobial-coated central venous
catheters (CVC) in stem cell transplantation settings, where CVC-related infections
impose major threat to severely immunocompromised patients.